The Impact of the COVID-19 Pandemic on Psychological Distress, Physical Activity, and Symptom Severity in Parkinson’s Disease
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Background: The ongoing COVID-19 pandemic has many consequences for people with Parkinson’s disease (PD). Social distancing measures complicate regular care and result in lifestyle changes, which may indirectly cause psychological stress and worsening of PD symptoms. Objective: To assess whether the COVID-19 pandemic was associated with increased psychological distress and decreased physical activity in PD, how these changes related to PD motor and non-motor symptom severity, and what frequency and burden of COVID-related stressors were. Methods: We sent an online survey to the Personalized Parkinson Project (PPP) cohort ( n = 498 PD patients) in the Netherlands. In the survey, we distinguished between COVID-related stressor load, psychological distress, PD symptom severity, and physical activity. We related inter-individual differences to personality factors and clinical factors collected before the pandemic occurred. Results: 358 PD patients completed the survey between April 21 and May 25, 2020 (response rate 71.9%). Patients with higher COVID-related stressor load experienced more PD symptoms, and this effect was mediated by the degree of psychological distress. 46.6% of PD patients were less physically active since the COVID-19 pandemic, and reduced physical activity correlated with worse PD symptoms. Symptoms that worsened most were rigidity, fatigue, tremor, pain and concentration. Presence of neuropsychiatric symptoms (anxiety, depression) before the pandemic, as well as cognitive dysfunction and several personality traits predicted increased psychological distress during the COVID-19 pandemic. Conclusion: Our findings show how an external stressor (the COVID-19 pandemic) leads to a worsening of PD symptoms by evoking psychological distress as well as lifestyle changes (reduced physical activity).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Individuals with PD, particularly those with preexisting neuropsychiatric symptoms and lower cognitive baseline reported increased severity of anxiety, depression, and motor symptoms as a result of pandemic-related stressors (van der Heide et al., 2020).”
From Online Mindfulness-Based Cognitive Therapy for People with Parkinson’s Disease and Their Caregivers: a Pilot Study (2022) · cites this paper as van der Heide et al., 2020
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The social isolation imposed by the COVID-19 pandemic greatly affected people with PD (Brown et al., 2020; van der Heide et al., 2020).”
From Online Mindfulness-Based Cognitive Therapy for People with Parkinson’s Disease and Their Caregivers: a Pilot Study (2022) · cites this paper as van der Heide et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Global Measure of Perceived Stress
Cohen, S., Kamarck, T., & Mermelstein, R. (1983) · Journal of Health and Social Behavior · doi:10.2307/2136404 · Cited by 32,807
The Psychological Impact of Quarantine and How to Reduce It: Rapid Review of the Evidence
Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N., & Rubin, G. J. (2020) · doi:10.2139/ssrn.3532534 · Cited by 16,394
The psychological impact of quarantine and how to reduce it: Rapid review of the evidence
Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N., & Rubin, G. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30460-8 · Cited by 16,378
You want to measure coping but your protocol’ too long: Consider the brief cope
Carver, C. S. (1997) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm0401_6 · Cited by 7,361
Social Relationships and Health
House, J. S., Landis, K. R., & Umberson, D. (1988) · Science · doi:10.1126/science.3399889 · Cited by 7,073 · cited 1×
“This is in line with previous studies in healthy people [28, 38, 39].”
ResultThe brief resilience scale: Assessing the ability to bounce back
Smith, B. W., Dalen, J., Wiggins, K., Tooley, E., Christopher, P., & Bernard, J. (2008) · International Journal of Behavioral Medicine · doi:10.1080/10705500802222972 · Cited by 6,439 · cited 1×
“Elements that we copied from DynaCORE-C were the SOZU-K-10 on perceived social support [22], the Brief Resilience Scale [23], the neuroticism subscale of the Big Five Inventory 10 [24], a selection of 10 items from the brief COPE [25] and 12 items from the Cognitive Emotion Regulation Questionnaire…”
MethodNolen-Hoeksema, S., Wisco, B. E., & Lyubomirsky, S. (2008) · Perspectives on Psychological Science · doi:10.1111/j.1745-6924.2008.00088.x · Cited by 5,172 · cited 1×
“In addition, we added the subscale of the Parkinson Anxiety Scale (PAS) [20] measuring episodic anxiety and the brooding subscale of the Rumi-native Response Scale (RRS) [21].”
MethodHayes, A. F., & Rockwood, N. J. (2017) · Behaviour Research and Therapy · doi:10.1016/j.brat.2016.11.001 · Cited by 2,350 · cited 1×
“Our hypothesis that PSS mediates the association between stressor load and symptom severity was tested using the PROCESS macro developed by Hayes (2013) [29], in which the 95% confidence interval of the indirect effects was obtained with 5,000 bootstrap samples.”
MethodScheier, M. F., & Carver, C. S. (1992) · Cognitive Therapy and Research · doi:10.1007/bf01173489 · Cited by 2,220 · cited 1×
“This is in line with previous studies in healthy people [28, 38, 39].”
ResultPsychological interventions for people affected by the COVID-19 epidemic
Duan, L., & Zhu, G. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30073-0 · Cited by 1,885
Research works printed but not linked: 1
- 10.1002/1531-8257(199903)14:2<242::AID-MDS1007>3.0.CO;2-W · doi:10.1002/1531-8257(199903)14:2<242::aid-mds1007>3.0.co;2-w
Cited by
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
Amruta, N., Chastain, W. H., Paz, M., Solch-Ottaiano, R. J., Murray-Brown, I. C., Befeler, J. B., Gressett, T. E., Longo, M. T., Engler-Chiurazzi, E. B., & Bix, G. J. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.02.002 · Cited by 128
Stress and mindfulness in Parkinson’s disease – a survey in 5000 patients
van der Heide, A., Speckens, A. E. M., Meinders, M. J., Rosenthal, L. S., Bloem, B. R., & Helmich, R. C. (2021) · npj Parkinson's Disease · doi:10.1038/s41531-020-00152-9 · Cited by 82
Self-citationStress and Mindfulness in Parkinson's Disease: Clinical Effects and Potential Underlying Mechanisms
van der Heide, A., Meinders, M. J., Speckens, A. E. M., Peerbolte, T. F., Bloem, B. R., & Helmich, R. C. (2021) · Movement Disorders · doi:10.1002/mds.28345 · Cited by 80
“PD that coronavirus disease (COVID)-related stress was associated with increased (self-reported) severity of not only motor and neuropsychiatric symptoms (anxiety and depression), but also of nonmotor symptoms, such as pain, constipation, and sleeping difficulties.(6) Third, dopaminergic medication can be less effecti…”
BackgroundSelf-citationNand, S., Tiwari, N. K., Singh, P., Singh, S. P., Mishra, D., Imran, M., Singh, S., Hooshmandi, E., Vamanu, E., Singh, S. K., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3012778 · Cited by 72
Nasal Microbiota, Olfactory Health, Neurological Disorders and Aging—A Review
Thangaleela, S., Sivamaruthi, B. S., Kesika, P., Bharathi, M., & Chaiyasut, C. (2022) · Microorganisms · doi:10.3390/microorganisms10071405 · Cited by 67
Suzuki, K., Numao, A., Komagamine, T., Haruyama, Y., Kawasaki, A., Funakoshi, K., Fujita, H., Suzuki, S., Okamura, M., Shiina, T., et al. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212560 · Cited by 58
Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease
Bianchini, E., Onelli, C., Morabito, C., Alborghetti, M., Rinaldi, D., Anibaldi, P., Marcolongo, A., Salvetti, M., & Pontieri, F. E. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.909197 · Cited by 54
Huang, P., Zhang, L., Tan, Y., & Chen, S. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00337-1 · Cited by 63
Brooks, S. K., Weston, D., & Greenberg, N. L. (2021) · Public Health · doi:10.1016/j.puhe.2021.08.014 · Cited by 55
Balcı, B., Aktar, B., Buran, S., Tas, M., & Çolakoğlu, B. D. (2021) · International Journal of Rehabilitation Research · doi:10.1097/mrr.0000000000000460 · Cited by 43
de Boer, D. R., Hoekstra, F., Huetink, K. I. M., Hoekstra, T., Krops, L. A., & Hettinga, F. J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18126342 · Cited by 46
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic
Montanaro, E., Artusi, C. A., Rosano, C., Boschetto, C., Imbalzano, G., Romagnolo, A., Bozzali, M., Rizzone, M. G., Zibetti, M., & Lopiano, L. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05286-z · Cited by 39
Bronskill, S. E., Maclagan, L. C., Maxwell, C. J., Iaboni, A., Jaakkimainen, R. L., Marras, C., Wang, X., Guan, J., Harris, D. A., Emdin, A. L., et al. (2022) · JAMA Health Forum · doi:10.1001/jamahealthforum.2021.4599 · Cited by 40
Kitani‐Morii, F., Kasai, T., Horiguchi, G., Teramukai, S., Ohmichi, T., Shinomoto, M., Fujino, Y., & Mizuno, T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245864 · Cited by 41
Predictors of stress resilience in Parkinson’s disease and associations with symptom progression
van der Heide, A., Dommershuijsen, L. J., Puhlmann, L. M. C., Kalisch, R., Bloem, B. R., Speckens, A. E. M., & Helmich, R. C. G. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00692-4 · Cited by 35
Self-citationKim, A., Yun, S. J., Sung, K.-S., Kim, Y., Jo, J. Y., Cho, H., Park, K., Oh, B., & Seo, H. G. (2021) · JMIR mhealth and uhealth · doi:10.2196/27662 · Cited by 41
Trinh, J., de Vries, N. M., Chan, P., Dekker, M. C. J., Helmich, R. C. G., & Bloem, B. R. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00305-9 · Cited by 49
Self-citationLotzin, A., Ketelsen, R., Novaković, I. Z., Lueger‐Schuster, B., Böttche, M., & Schäfer, I. (2022) · BMC Psychology · doi:10.1186/s40359-022-00790-z · Cited by 44
Fabbri, M., Leung, C., Baille, G., Béreau, M., Brefel‐Courbon, C., Castelnovo, G., Carrière, N., Damier, P., Defebvre, L., de Maindreville, A. D., et al. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.07.013 · Cited by 27
The Impact of COVID-19 Pandemic on the Levels of Physical Activity: A Systematic Review
Mehraeen, E., Karimi, A., Mirghaderi, P., Mirzapour, P., Pashaei, Z., Qaderi, K., Afsahi, A. M., Barzegary, A., Mohammadi, P., Shojaei, A., et al. (2023) · Infectious Disorders - Drug Targets · doi:10.2174/1871526523666230120143118 · Cited by 33
COVID-19 Vaccination for Persons with Parkinson’s Disease: Light at the End of the Tunnel?
Bloem, B. R., Trenkwalder, C., Sánchez‐Ferro, Á., Kalia, L. V., Alcalay, R. N., Chiang, H., Kang, U. J., Goetz, C. G., Brundin, P., & Papa, S. M. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212573 · Cited by 28
Self-citationYang, Y., Fu, X., Zhang, H., Ouyang, G., & Lin, S.-C. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04595-6 · Cited by 31
Leavy, B., Hagströmer, M., Conradsson, D. M., & Franzén, E. (2021) · Neurology Report · doi:10.1097/npt.0000000000000372 · Cited by 24
Wang, S., Peng, Y., Fan, P., Ye, J.-R., Ma, W.-Y., Wu, Q.-L., Wang, H., Tian, Y., He, W., Xu, Y., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01374-w · Cited by 24
COVID-19 and Parkinson’s disease: a systematic review and meta-analysis
Afraie, M., Moradi, G., Mohammadzadeh, P., Azami, M., Riyahifar, S., & Moradi, Y. (2022) · Acta Neurologica Belgica · doi:10.1007/s13760-022-02141-6 · Cited by 27
Dance as Lifeline: Transforming Means for Engagement and Connection in Times of Social Isolation
Kelly, M. P., & Leventhal, D. (2021) · Health Promotion Practice · doi:10.1177/1524839921996332 · Cited by 25
Life with Parkinson’s Disease During the COVID-19 Pandemic: The Pressure Is “OFF”
Thomsen, T. H., Wallerstedt, S. M., Winge, K., & Bergquist, F. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202342 · Cited by 21
Similarities, differences and overlaps between frailty and Parkinson's disease
Ebina, J., Ebihara, S., & Kano, O. (2022) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14362 · Cited by 24
COVID-19 and Physical Activity Behaviour in People with Neurological Diseases: A Systematic Review
Abasıyanık, Z., Kurt, M., & Kahraman, T. (2022) · Journal of Developmental and Physical Disabilities · doi:10.1007/s10882-022-09836-x · Cited by 26
Dommershuijsen, L. J., van der Heide, A., den Berg, E. M. V., Labrecque, J. A., Ikram, M. K., Ikram, M. A., Bloem, B. R., Helmich, R. C. G., & Darweesh, S. K. L. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00238-y · Cited by 26
Self-citationAraldi, R. P., Prezoto, B. C., Gonzaga, V. F., Policiquio, B. D. O., Mendes, T. B., D’Ámelio, F., Vigerelli, H., Viana, M. D. N., Valverde, C. W., Pagani, E., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112920 · Cited by 21
International survey for assessing COVID-19’s impact on fear and health: study protocol
Lok, K. Y. W., Fong, D., Wong, J. Y. H., Ho, M. M., Choi, E. P. H., Pandian, V., Davidson, P. M., Duan, W., Tarrant, M., Lee, J. J., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-048720 · Cited by 22
Worsened Parkinson’s Disease Progression: Impact of the COVID-19 Pandemic
Ineichen, C., Baumann‐Vogel, H., Sitzler, M., Waldvogel, D., & Baumann, C. R. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212779 · Cited by 20
SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now
Boura, I., Qamar, M. A., Daddoveri, F., Leta, V., Popławska-Domaszewicz, K., Falup‐Pecurariu, C., & Chaudhuri, К. R. (2023) · Biomedicines · doi:10.3390/biomedicines11092524 · Cited by 21
Jacquet, A. D. R., Bogard, S., Normandeau, C. P., Degroot, C., Postuma, R. B., Dupré, N., Miyasaki, J. M., Monchi, O., Martino, D., Fon, E. A., et al. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.08.018 · Cited by 20
Movement Disorders Associated with COVID-19
Salari, M., Harofteh, B. Z., Etemadifar, M., Sedaghat, N., & Nouri, H. (2021) · Parkinson s Disease · doi:10.1155/2021/3227753 · Cited by 18
Seritan, A. L., Iosif, A.-M., Prakash, P., Wang, S. S., & Eisendrath, S. (2022) · Journal of Technology in Behavioral Science · doi:10.1007/s41347-022-00261-7 · Cited by 16
Shaibdat, N. S., Ahmad, N., Azmin, S., & Ibrahim, N. M. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1136858 · Cited by 16
Cavallieri, F., Sireci, F., Fioravanti, V., Toschi, G., Rispoli, V., Antonelli, F., Costantini, M., Ghirotto, L., & Valzania, F. (2021) · European Journal of Neurology · doi:10.1111/ene.14745 · Cited by 16
Haas, A. N., Monteiro, E. P., Delabary, M. D. S., Moratelli, J., Schuch, F. B., Corrêa, C. L., Sonza, A., Guimarães, A. C. D. A., & Peyré‐Tartaruga, L. A. (2022) · Sport Sciences for Health · doi:10.1007/s11332-021-00868-y · Cited by 20
Chaudhuri, К. R., Rukavina, K., McConvey, V., Antonini, A., Lorenzl, S., Bhidayasiri, R., Piemonte, M. E. P., Lim, S., Richfield, E. W., Walker, R. W., et al. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1923480 · Cited by 15
Flynn, A., Preston, E., Dennis, S. M., Canning, C. G., & Allen, N. E. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09194-0 · Cited by 18
Nabizadeh, F., Seyedalhosseini, Z., Balabandian, M., & Rostami, M. R. (2022) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2022.06.017 · Cited by 17
Stuckenschneider, T., Abeln, V., Foitschik, T., Abel, T., Polidori, M. C., & Strüder, H. K. (2021) · Brain and Behavior · doi:10.1002/brb3.2352 · Cited by 15
Soilemezi, D., Roberts, H. C., Sánchez, M. V. N., Kunkel, D., Ewings, S. M., Reidy, C., & Portillo, M. C. (2022) · Journal of Clinical Nursing · doi:10.1111/jocn.16367 · Cited by 13
A pilot study of a 12-week community-based boxing program for Parkinson’s disease
Patel, R. A., Blasucci, L. M., & Mahajan, A. (2022) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2022.12.006 · Cited by 14
Amo, C., Almansour, N., & Harvey, I. S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191811230 · Cited by 15
Mameli, F., Zirone, E., Capetti, B., Mellace, D., Ferrucci, R., Franco, G., Fonzo, A. D., Barbieri, S., & Ruggiero, F. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.939520 · Cited by 12
Santini, S., Rampioni, M., Stara, V., Rosa, M. D., Paciaroni, L., Paolini, S., Fioretti, S., Valenza, S., Riccardi, G. R., & Pelliccioni, G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192214844 · Cited by 14
A 6-month longitudinal study on worsening of Parkinson’s disease during the COVID-19 pandemic
Shalash, A., Helmy, A. K., Salama, M., Gaber, A., El-Belkimy, M., & Hamid, E. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00376-x · Cited by 14
Barriers to Vaccination Among People with Parkinson’s Disease and Implications for COVID-19
Phanhdone, T., Drummond, P. S., Meisel, T., Friede, N., Rocco, A. D., Chodosh, J., & Fleisher, J. E. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202497 · Cited by 11
Fründt, O., Hanff, A.-M., Mai, T., Kirchner, C., Mazery, E. B. D., Amouzandeh, A., Buhmann, C., Krüger, R., & Südmeyer, M. (2021) · Brain Sciences · doi:10.3390/brainsci12010062 · Cited by 10
Ruggiero, F., Lombi, L., Molisso, M. T., Fiore, G., Zirone, E., Ferrucci, R., Pirola, E., Locatelli, M., Barbieri, S., & Mameli, F. (2022) · Healthcare · doi:10.3390/healthcare10061065 · Cited by 10
Impulse Control Disorders in Parkinson's Disease: Has COVID‐19 Related Lockdown Been a Trigger?
Suárez, P. R., Martínez‐Fernández, R., Natera‐Villalba, E., Pareés, I., Martínez‐Castrillo, J. C., & Cánovas, A. A. (2021) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13276 · Cited by 14
Wolff, A. W., Haller, B., Demleitner, A. F., Westenberg, E., & Lingor, P. (2022) · Brain Sciences · doi:10.3390/brainsci12030353 · Cited by 10
SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms
Motyl, J. A., Gromadzka, G., Czapski, G. A., & Adamczyk, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212079 · Cited by 9
Mai, A. S., Yong, J. H., Tan, B. J., Xiao, B., & Tan, E. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51616 · Cited by 11
Psychological impact of COVID-19 pandemic on Parkinson's disease patients
Tufail, M., & Wu, C. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09604 · Cited by 9
Impact of COVID-19 on Neuropsychiatric Disorders
Zia, N., Ravanfar, P., Allahdadian, S., & Ghasemi, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175213 · Cited by 9
Zimmers, S., Robieux, L., & Bungener, C. (2023) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887231154932 · Cited by 9
Conradsson, D. M., Leavy, B., Hagströmer, M., & Franzén, E. (2023) · Neurology Report · doi:10.1097/npt.0000000000000455 · Cited by 8
Tondo, G., Aprile, D., Tesser, F., & Comi, C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10215169 · Cited by 7
Covid-19 and Parkinson's disease: Nursing care, vaccination and impact on advanced therapies
Roszmann, A., Podlewska, A. M., Lau, Y. H., Boura, I., & Hand, A. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.04.005 · Cited by 6
Martini, S., Magistrelli, L., Vignaroli, F., Colombatto, F., Comi, C., & Cosentino, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113007 · Cited by 6
Eccles, F. J. R., Garner, I. W., Murray, C. D., Doyle, C., & Simpson, J. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120768 · Cited by 6
Kong, A. P. (2021) · Open Journal of Social Sciences · doi:10.4236/jss.2021.95031 · Cited by 7
Fereshtehnejad, S., Rodríguez‐Violante, M., Ponce-Rivera, M. S., Martínez-Ramírez, D., & Ramirez‐Zamora, A. (2022) · Behavioral Sciences · doi:10.3390/bs12110447 · Cited by 6
Mordeno, I. G., Piape, Q. T., Roño, A. G. R., Abejar, W. A. C., Ferolino, M. A. L., & Mendoza, N. B. (2024) · Journal of Psychoeducational Assessment · doi:10.1177/07342829241229768 · Cited by 6
Impact of COVID-19 Pandemic on Parkinson's Disease: A Tale of Fears and Sorrows!
Kumar, N., & Gupta, R. (2021) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_97_21 · Cited by 5
Moving Forward from the COVID-19 Pandemic: Needed Changes in Movement Disorders Care and Research
Valdovinos, B. Y., Modica, J. S., & Schneider, R. B. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01178-7 · Cited by 6
Pauly, C., Glaab, E., Hansen, M., Martin‐Gallausiaux, C., Ledda, M., Marques, T. M., Wilmes, P., Krüger, R., & Diederich, N. J. (2022) · Movement Disorders · doi:10.1002/mds.29212 · Cited by 5
Kataoka, H., Obayashi, K., Tai, Y., Sugie, K., & Saeki, K. (2023) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2023.100194 · Cited by 4
The Hopkins Symptom Checklist (SCL-90-R): A Patient-Reported Outcome Measure in Parkinson’s Disease
Carrozzino, D., Christensen, K. S., Patierno, C., Siri, C., Zecchinelli, A., Pezzoli, G., & Cosci, F. (2021) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887211060020 · Cited by 5
Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico
León-García, R., Ortega‐Robles, E., & Arias-Carrión, Ó. (2023) · Brain Sciences · doi:10.3390/brainsci13071114 · Cited by 4
Spotlight on non-motor symptoms and Covid-19
Rota, S., Boura, I., Wan, Y.-M., Lazcano‐Ocampo, C., Rodríguez‐Violante, M., Antonini, A., & Chaudhuri, К. R. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.04.001 · Cited by 4
Matthews, T. A., Guardiano, M., Omidakhsh, N., Cushing, L. J., Robbins, W. A., Hong, O., & Li, J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010144 · Cited by 4
Bacanoiu, M. V., Dănoiu, M., Marin, M. I., Rusu, M. R., & Rusu, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030597 · Cited by 4
Goel, A., Narayan, S. K., & Sugumaran, R. (2022) · Acta Neurologica Belgica · doi:10.1007/s13760-022-01891-7 · Cited by 4
Gotheridge, H., Eccles, F. J. R., Murray, C. D., Henderson, R., & Simpson, J. (2024) · Disability and Rehabilitation · doi:10.1080/09638288.2024.2395460 · Cited by 3
Physical Activities and Prevention of Neurodegenerative Diseases
Joon, S., Singla, R. K., & Shen, B. (2022) · Springer eBooks · doi:10.1007/978-981-16-9162-1_8 · Cited by 3
Rezayi, S., Katigari, M. R., Shahmoradi, L., & Nilashi, M. (2023) · Parkinson s Disease · doi:10.1155/2023/6272982 · Cited by 2
Hattori, N., Okada, Y., Kawata, Y., Furusawa, Y., Imai, T., Yoshida, H., Ota, M., Arai, M., Shintani, A., & Fernandez, J. L. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s402193 · Cited by 3
van der Linden, M. L., Kos, D., Moumdjian, L., Kalron, A., Coote, S. B., Smedal, T., Arntzen, E. C., Tayfur, S. N., Pedullà, L., Tacchino, A., et al. (2023) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2023.101798 · Cited by 3
Delayed mental, neurological and somatic disorders associated with COVID-19
Belyakov, N. А., Рассохин, В. В., Totolyan, N. A., Boeva, E. V., Бобрешова, А. С., Khalezova, N. B., Kushnir, Y. B., & Norka, A. O. (2024) · HIV Infection and Immunosuppressive Disorders · doi:10.22328/2077-9828-2023-15-4-53-62 · Cited by 3
Fabbietti, P., Santini, S., Piccinini, F., Giammarchi, C., & Lamura, G. (2024) · Healthcare · doi:10.3390/healthcare12030383 · Cited by 3
Wolff, A. W., Haller, B., Demleitner, A. F., Pürner, D., Niederschweiberer, J., Cordts, I., Westenberg, E., & Lingor, P. (2023) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13727 · Cited by 3
The Impact of Social Distancing Due to COVID-19 on Activities of Daily Living in Parkinson’s Disease
Sánchez-Herrera-Baeza, P., Rodríguez-Pérez, M. P., Fernández-Gómez, G., Bustamante-Palomo, N., Serrada-Tejeda, S., Obeso‐Benítez, P., Morales-Cabezas, M., Martínez-Piédrola, R. M., & Pérez‐de‐Heredia‐Torres, M. (2023) · Healthcare · doi:10.3390/healthcare11121688 · Cited by 2
The questionnaire survey regarding the impact of COVID-19 pandemic on Parkinson’s disease patients
Tezuka, T., Osada, T., Terayama, Y., Kubota, M., Okusa, S., Shiihashi, G., Kubo, S., Suzuki, N., Nakahara, J., & Seki, M. (2021) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001663 · Cited by 2
Exercise for Reducing Pain and Stress: A Narrative Review
Field, T. (2023) · Current Research in Complementary & Alternative Medicine · doi:10.29011/2577-2201.100220 · Cited by 2
Paiva, K. M., Oliveira, R. F., Rocha, G. S., Morais, P. L. A. D. G., de Araújo, D. P., de Oliveira, L. C., Gúzen, F. P., & Cavalcanti, J. R. L. D. P. (2021) · Research Society and Development · doi:10.33448/rsd-v10i1.12043 · Cited by 2
Mitsushi, S., Ryuta, T., KADOTA, A., Takahiro, T., Yuri, Y., Takabatake, S., Yumi, S., Sotokawa, T., & Fujii, H. (2025) · Asian Journal of Human Services · doi:10.14391/ajhs.28.195 · Cited by 1
Neta, R. D. S. C., Batista, C. D. S., PALMERIM, É. M. M., Dias, H. M. C., Nóbrega, K. C. C., de Oliveira, C. A., & Visco, D. B. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.014 · Cited by 2
van der Heide, A., Kischkel, B., Bleeker‐Rovers, C. P., de Jonge, M. I., Bloem, B. R., Verbeek, M. M., Joosten, L. A. B., & Helmich, R. C. G. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01178-7 · Cited by 3
Self-citationZhang, Z., & Zhou, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1831208 · Cited by 1
Yılmaz, N. H., Kılıç, B. B., Zirh, A. T., Aslan, A., & Hanoğlu, L. (2022) · Medical Bulletin of Haseki · doi:10.4274/haseki.galenos.2022.8225 · Cited by 1
Heath management app use in Parkinson’s disease and quality of life during the COVID-19 pandemic
Tang, Y., Liang, X., Shen, B., Wang, J., Bloem, B. R., Wu, J., & Wang, J. (2023) · Communications Medicine · doi:10.1038/s43856-023-00246-4 · Cited by 3
Self-citationThe impact of COVID-19 on patients with Parkinson disease
Tur, E. K., & Arı, B. Ç. (2023) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1306662 · Cited by 1
Mert, U. S. T. A., ŞAFAK, M., YILDIZ, Z., & Başkurt, Z. (2024) · Ergoterapi ve Rehabilitasyon Dergisi · doi:10.30720/ered.1308585 · Cited by 1
Deenen, J. C. W., Kools, J., Greco, A., Thewissen, R., van de Put, W., Lanser, A., Joosten, L. A. B., Verbeek, A. L. M., van Engelen, B. G. M., & Voermans, N. C. (2024) · Acta Neurologica Belgica · doi:10.1007/s13760-023-02443-3 · Cited by 2
Ellis, P. K., Davies, M. L., Gray, W. K., Barber, M., Bolnykh, I., Sadler, M., & Walker, R. W. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223173 · Cited by 4
Metadata
- Authors
- van der Heide, A., Meinders, M. J., Bloem, B. R., & Helmich, R. C.
- Affiliations
- Radboud University Nijmegen, Donders Institute for Brain, Cognition, and Behaviour, Centre for Cognitive Neuroimaging, Nijmegen, the Netherlands
- Radboud University Nijmegen (NL)
- Corresponding author
- Helmich, Rick C.
- Venue
- Journal of Parkinson’s Disease
- Publisher
- SAGE Publications
- Published
- 2020-08-27
- Volume
- 10
- Issue
- 4
- Pages
- 1355-1364
- ISSN
- 1877-7171 (ISSN-L)
- 1877-718X
- PMC
- PMC7683090
- OpenAlex
- W3086957843
- Cited by
- 126
- References
- 42
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 18 · 2023: 21 · 2022: 43 · 2021: 32 · 2020: 1
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (unspecified)
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Parkinson s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- Michael J. Fox Foundation for Parkinson's Research
- National Parkinson Foundation
- Parkinson's Foundation
- Radboud Universiteit
- Radboud Universitair Medisch Centrum
- Parkinsonfonden
- Topics
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- COVID-19 pandemic, Parkinson's disease, psychological distress, physical activity, symptom severity, social distancing, rigidity, fatigue, tremor, pain, neuropsychiatric symptoms, cognitive impairment, personality traits, mediation
- MeSH terms
- Psychological Distress, COVID-19, Aged, Female, Humans, Longitudinal Studies, Male, Middle Aged, Parkinson Disease, Pneumonia, Viral, Surveys and Questionnaires, Severity of Illness Index, Exercise, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.